Paratek Pharmaceuticals, Inc. Annual Cost of Revenue in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from 2019 to 2022.
  • Paratek Pharmaceuticals, Inc. Cost of Revenue for the quarter ending June 30, 2023 was $4.37M, a 10.5% decline year-over-year.
  • Paratek Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending June 30, 2023 was $25.3M, a 45.6% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Cost of Revenue for 2022 was $23.1M, a 7.06% increase from 2021.
  • Paratek Pharmaceuticals, Inc. annual Cost of Revenue for 2021 was $21.5M, a 149% increase from 2020.
  • Paratek Pharmaceuticals, Inc. annual Cost of Revenue for 2020 was $8.65M, a 148% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $23.1M +$1.52M +7.06% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $21.5M +$12.9M +149% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $8.65M +$5.17M +148% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $3.48M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.